Ex-Watson COO joins Cardinal
Executive Summary
Cardinal Health names former Watson COO Joseph Papa as CEO-pharmaceutical technologies and services business. Papa will be responsible for drug development, formulation, sterile manufacturing, packaging and marketing services. Papa chose not to remain at Watson as president-brand business under the company's reorganization (1"The Pink Sheet" Nov. 1, 2004, p. 22)...
You may also be interested in...
Watson Restructuring To Create Brand, Generic Units
Watson believes it may take up to six months to complete its search for two presidents to head up the company's new brand and generic business units
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.